 - Current or recent within 3 months of study drug administration gastrointestinal disease or surgery, which by the judgment of the Investigator, may increase a subjects risk of gastrointestinal bleeding or interfere with absorption of study drug e.g., peptic or gastric ulcer disease, severe gastritis, history of gastrointestinal surgery. 